News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Mergers and Acquisitions (World)
Shire (SHPG) Goes Live on Rebuffed $30 Billion Merger with Baxalta to Pressure Stockholders, Board and Execs 8/4/2015
Horizon Pharma (HZNP) Files Lawsuit, Seeks Change of Depomed (DEPO)’s Board of Directors in Takeover Attempt 8/4/2015
Royal Philips Electronics N.V. (PHG) Working with Bank of America (BAC) as it Scouts for M&A 8/4/2015
Endo Pharmaceuticals (ENDP) Completes Divestiture Of American Medical Systems, Inc. (AMMD)' Men's And Prostate Health Businesses To Boston Scientific (BSX) 8/4/2015
Teva (TEVA) Secures $33.75 Billion Financing Commitment 8/3/2015
Dechra To Acquire 63.3% Shareholding (£19.4m) In Genera D.D. Croatia 8/3/2015
Teva (TEVA) And Immuneering Announce Teva’s Purchase Of 51% Equity Share Of Genomic-Analysis Company 8/3/2015
TiGenix Snaps Up Coretherapix In Deal Worth $318.5 Million 7/31/2015
Months Later, Ex-Allergan (AGN) CEO Is Still Going After Ackman's Pershing Square 7/31/2015
Merck & Co. (MRK) Snaps up Israel Oncology Firm cCam Biotherapeutics for $605 Million 7/29/2015
Allergan (AGN) Could Set its Sights on Another Transformative M&A Deal With Biogen (BIIB), Amgen (AMGN) or AbbVie (ABBV) 7/29/2015
Mallinckrodt (MNK) Divests Contrast Media Biz to Guerbet (GBT) For $270 Million 7/28/2015
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal 7/28/2015
Gerresheimer Will Acquire Centor - Higher Profitability Expected 7/28/2015
Hikma (HIK.L) Snags Boehringer Ingelheim's U.S. Generics Biz for $2.65 Billion 7/28/2015
Allergan (AGN) Coughs Up $560 Million Cash for Naurex 7/27/2015
Teva (TEVA) Snaps Up Allergan (AGN) Generics for $40.5 Billion, Ends Pursuit of Mylan (MYL) 7/27/2015
Lupin (LUPN.BO) Acquires Specialty Product Portfolio In Germany 7/27/2015
Teva (TEVA) Withdraws Proposal To Acquire Mylan (MYL) 7/27/2015
3SBio Inc. (SSRX) Acquires Zhejiang Wansheng Pharmaceutical 7/24/2015
Lupin (LUPN.BO) Plunks Down $880 Million for Privately Held Gavis Pharmaceuticals 7/23/2015
Veeva Systems, Inc. OpenData Expands To Italy With The Acquisition Of Merqurio's Healthcare Professional And Organisation Database 7/23/2015
Scandal-Plagued Toshiba Abandans Elevator Biz for $943 MIllion 7/23/2015
Depomed (DEPO) Gets Sweetened $33 Per Share Offer From Horizon Pharma (HZNP) 7/21/2015
Stryker Snaps Up Muka Metal for Undisclosed Sum 7/20/2015
Shanghai's Phagelux Buys Agricultural Phage Company, OmniLytics 7/20/2015
Phagelux Announces Acquisition Of Omnilytics 7/20/2015
Mindray Medical Completes Acquisition Of Wuhan Dragonbio 7/17/2015
AMRI (AMRI) Coughs Up $174 Million for Gadea Pharma 7/16/2015
Canbridge Acquires License For Apogenix’s APG101 Onco-Immunotherapy In Glioblastoma For China 7/15/2015
Amarantus BioSciences, Inc. Completes Acquisition Of ESS From Lonza Group Ltd. (LZAGY.PK) For The Treatment Of Severe Burns 7/15/2015
AMCo Acquires Australian Company Boucher And Muir 7/14/2015
Roche (RHHBY) Denies Deal Has Been Struck for Vacant New Jersey Site 7/13/2015
Medtronic (MDT) Bags RF Surgical in $235 Million Deal 7/13/2015
German Kartellamt Greenlights Acquisition Of Three BASF Sites 7/13/2015
Celsus Therapeutics (CLTX) Grabs Volution Immuno Pharma in All-Stock Deal; Combined Company to be Renamed Akari Therapeutics 7/13/2015
AstraZeneca PLC (AZN) Offloads Crohn's Disease Drug for $215 Million 7/10/2015
Smith & Nephew plc (SNN) Snags Russian Manufacturing Biz for Undisclosed Sum 7/10/2015
Benitec (BLT.AX) Acquires Full Rights To Hepatitis B Program 7/9/2015
Heraeus Takes Major Stake in SoCal's Ankasa Regenerative Therapeutics 7/9/2015
Horizon Pharma (HZNP) Goes Hostile With $3 Billion Bid for Depomed (DEPO) 7/7/2015
Allergan (AGN) Slams Down $250 Million+ for Rights to Merck & Co. (MRK)'s Migraine Drugs 7/7/2015
Allergan (AGN) Forks Over $125 Million+ for Bay Area Medtech Firm Oculeve 7/6/2015
Adapt Pharma Acquires Narcan NDA And Obtains License To The Narcan Trademark 7/2/2015
Konica Minolta Medical Imaging U.S.A, Inc. (KPI1.BE) Acquires Sawae, Enhancing Digital X-Ray Diagnostic Imaging Systems In Brazil 7/2/2015
Hikma (HIK.L) Rumored to Be Bidding $2.2B for Boehringer Ingelheim's Roxane Laboratories, As Mallinckrodt (MNK), Perrigo (PRGO) Circle 6/30/2015
Roche (RHHBY) Investors Urging Company to Dump Diabetes Unit May Have to Wait 6/30/2015
PharmaVentures Ltd Completes M&A Deal For Technology In The Stem Cell & Regenerative Medicine Sector 6/30/2015
Novartis AG (NVS) Beefs Up Pain Pipeline With $200 Million+ Spinifex Buy 6/29/2015
BSN Medical GmbH Bags FarrowMed for Undisclosed Sum 6/29/2015
Cellular Biomedicine Group (CBMG) Completes Acquisition Of CD40LGVAX Vaccine 6/29/2015
Johnson & Johnson (JNJ), Roche (RHHBY) Allegedly Circle GlaxoSmithKline (GSK) as Takeover Speculation Intensifies 6/26/2015
The Medicines Company (MDCO) May Sell European Business As Management Focuses Inward 6/26/2015
Cinven to Buy Synlab Following Recent Acquisition of Labco S.A. 6/26/2015
Sorin Group S.p.A. (SRN) and Cyberonics (CYBX) Unveil Name of Combined Company: LivaNova 6/25/2015
3SBio Inc. (SSRX) Acquires Global Rights to Bay Area Apexigen’s Anti-TNF mAb 6/22/2015
Teva (TEVA) Completes The Purchase Of 4.61 Percent Interest In Mylan (MYL) 6/19/2015
Actavis (ACT) Officially Changes Name to Allergan (AGN) 6/18/2015
Sandalwood Oil Producer TFS Acquires ViroXis and Santalis in Deal Worth Up to $270 Million 6/18/2015
Allergan (AGN) Coughs Up $2.1 Billion for Double-Chin Drugmaker Kythera (KYTH) 6/18/2015
AMAG (AMAG) CEO Hunts for Another Big Buy 6/17/2015
Debiopharm Acquires FibroTrap Sample Processing Technology From Spinomix 6/16/2015
Bayer (BAY) Sells Diabetes Care Biz to Panasonic Healthcare for $1.15 Billion 6/11/2015
Altan Pharma Announces Acquisition Of The GES Group, A Specialty Pharmaceutical Company Based In Spain 6/11/2015
Actelion (ALIOF.PK) Hits All Time High on Rumored $18.9 Billion Shire (SHPGY) Bid 6/9/2015
Cellular Biomedicine Group (CBMG) Enters Into Definitive Agreement To Acquire CD40LGVAX Vaccine And Related Technologies And Know-How Which Will Be Used In A Pending PD-1 Combination Clinical Trial In The U.S. For Non-Small Cell Lung Cancer (NSCLC) 6/9/2015
Sobi Stock Plunges After Rumored Pfizer (PFE) or Biogen (BIIB) Acquisition Was Terminated 6/8/2015
Teva (TEVA) Buys Stake in Mylan (MYL), As Takeover Attempt Turns Nasty 6/5/2015
Runaway Bride Novartis AG (NVS) Leaves Gamida Cell At the Altar for Second Time, Will Pay $142M Breakup Fee 6/3/2015
Luye Pharma Stops $1 Billion Acquisition Of Beijing Jialin 6/3/2015
While Mylan (MYL) and Teva (TEVA) Continue Bickering, Perrigo (PRGO) Snaps Up OTC Portfolio From GlaxoSmithKline (GSK) 6/2/2015
Rumored Pfizer (PFE) Deal to Buy CRISPR for $1.64 Billion Could Lock in CRISPR and CAR T Tech 6/1/2015
Cipla, Lupin (LUPN.BO) Make Bid for UCB SA’s $1 Billion Generics Unit 6/1/2015
Actavis (ACT) Completes Acquisition Of Auden Mckenzie 6/1/2015
Mylan (MYL) CEO Says Pfizer (PFE) Should Come Calling, As Next Big Deal Speculation Swirls 5/29/2015
Bayer (BAY) CEO May Use Spinoff Cash for Animal Health Opportunities Such as Zoetis (ZTS), Analysts Say 5/29/2015
Youbo Pharma Acquired By Jiuzhitang In $1 Billion Reverse Takeover 5/27/2015
Retrophin (RTRX) Banks $245 Million From Sanofi (SAN.PA) for Priority Review Voucher 5/27/2015
Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline (GSK) and Pfizer (PFE) 5/22/2015
Fosun Pharma, HOPU Investments, CEL Healthcare Fund, And WuXi PharmaTech Co., Ltd. To Jointly Acquire U.S. Innovative Biotechnology Company Ambrx, Inc. 5/22/2015
Novartis Pharma AG (NVS) Unloads Certain Specialty Product Rights to Merus for $29.5 Million 5/22/2015
Strides Arcolab Limited Ponies Up $299.90 Million for Aspen Pharmacare's Drug Brands 5/21/2015
Cadila Close to Buying Rival CLARIS Lifesciences for About $534 Million: Report 5/21/2015
New York's Kinex Expected to Hire 80 to 240 Immediately, 800 Over Next Two Years 5/20/2015
Is Bayer (BAY) Eyeing Sirtex Medical (SRX.AX)? 5/19/2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? 5/19/2015
Ipsen (IPN.PA) Strengthens Its Presence In The Oncology Field With The Acquisition Of Octreopharm Sciences, A Company Developing Innovative Radiopharmaceuticals For The Diagnosis And Treatment Of Neuroendocrine Tumors 5/19/2015
How GlaxoSmithKline (GSK)'s Much-Criticized Chief's Strategy Differs From His Peers 5/18/2015
Mylan (MYL) Chairman Tells Investors He Would Consider Buying Rival Teva (TEVA) 5/18/2015
Pharmaxis (PXS.AX) Shares Catapult on $750 Million Liver Drug Sale to Boehringer Ingelheim 5/18/2015
ADM Grows Sweetener Business In China With Agreement To Purchase Meiweiyuan Biotechnology 5/18/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Floated as Possible Suitors For Freshly Flush Galapagos (GLPG.BR) 5/15/2015
Circassia (CIR.L) Drops $377 Million for Two Asthma Firms, Aerocrine and Prosonix 5/15/2015
Siegfried: RAG -Stiftung Beteiligungsgesellschaft mBH To Participate In Financing Of Latest Acquisition 5/13/2015
Pfizer (PFE) Pays $87.5 Million for Stake in AM-Pharma, With Option to Swallow Entire Company 5/12/2015
Perrigo (PRGO) Acquires Patheon (PTI.TO)'s Mexican Operations for $34 Million Cash 5/12/2015
Santen Pharmaceutical Announces Assignment Of Its Anti-Rheumatic Pharmaceuticals Business To Hyperion Pharma 5/12/2015
Endo Pharmaceuticals (ENDP) Shells Out $130 Million for Nearly 70 Pipeline Programs From Aspen Pharmacare 5/11/2015
Yew Bio-Pharm Group Signs The Tripartite Joint Planting Auricularia Auricula Contract And Acquires Financial Supporting From BiCOM 5/11/2015
Gilead (GILD) Finally Spends Some Money With $65 Million Buy 5/8/2015
Abbott (ABT) May Be Hunting for M&A With Cash Reaped From Mylan (MYL)'s Three-Way Tussle 5/8/2015
Golden Meditech Proposes To Purchase CCBC Convertible Notes Held By Magnum And CCBC Convertible Notes And CCBC Shares Held By CGL 5/8/2015
Syngenta AG (SYT) Rejects $45 Billion Takeover Offer From Monsanto Company (MON) 5/8/2015
Opko Health (OPK) Snaps Up EirGen for $135 Million 5/7/2015
Guizhou Xinbang Pharma Buys Hangzhou Chinese Peptide For $323 Million 5/6/2015
ECUPHAR Enters The Spanish And Southern European Markets Through ESTEVE 5/6/2015
Cipher Pharma (DND.TO) Acquires Canadian Commercialization Rights To Vaniqa And Actikerall 5/6/2015
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015
OphthaliX Inc. Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
Pfizer (PFE) Confirmed to be Mystery Bidder of $4.3 Billion Sobi 5/4/2015
Can-Fite BioPharma (CFBI) Subsidiary, OphthaliX, Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
Mylan (MYL) Ups Bid for Perrigo (PRGO) to $32.7B, As M&A Hungry Hippos Continues 4/29/2015
Will Pfizer (PFE) Make a Play for Struggling GlaxoSmithKline (GSK)? 4/29/2015
In Testy Letter to Teva (TEVA)'s CEO, Mylan (MYL) Rejects Its $40B Bid, Questions Credibility 4/28/2015
Resverlogix (RVX.TO) CEO Says It's in Talks With Suitors, After $100M in Q1 Deals 4/28/2015
Sobi Waves For Sale Sign at Big Pharmas Like Pfizer (PFE), Biogen (BIIB) 4/27/2015
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share 4/27/2015
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion 4/24/2015
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL) 4/23/2015
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again 4/23/2015
Teva (TEVA) Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Mylan (MYL) 4/22/2015
BREAKING: Perrigo (PRGO) Rejects $30B Mylan (MYL) Bid, Says Deal "Substantially Undervalues" Irish Firm 4/21/2015
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015 4/21/2015
Actelion Ltd. (ALIOF.PK) CFO Actively Hunting for M&A Opportunities 4/21/2015
Teva (TEVA) Will Bid For Mylan (MYL), Say Sources, As Tug-of-War Continues 4/20/2015
Daiichi Sankyo Dumps $3.6 Billion Sun Pharma (SUNPHARMA.NS) Stake 4/20/2015
Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource 4/17/2015
Mallinckrodt (MNK) Completes Acquisition Of Ikaria 4/17/2015
Karo Bio AB Acquires Product For Treatment Of Common Cold 4/10/2015
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 4/2/2015
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India 4/1/2015
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/31/2015
Japan's FUJIFILM to Acquire U.S. Cellular Dynamics for $307M 3/31/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/31/2015
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015
Columbia Laboratories, Inc. (CBRX) Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 3/30/2015
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 3/30/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
APR Applied Pharma Research S.A. Today Announced That HBM Partners AG (“HBM”) Has Acquired A Minority Stake In APR 3/25/2015
Life Post-Ranbaxy Laboratories (RANBAXY.BO)? Sun Pharma (SUNPHARMA.NS) Holds On to $300 Million and Hunts for More M&As 3/25/2015
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/23/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis 3/23/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout 3/20/2015
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015
Employees at Three Major Biopharmas Remain Uncertain, As Salix (SLXP) Confirms Bid From Endo International (ENDP) 3/13/2015
GlaxoSmithKline (GSK) Pockets $853 Million by Halving Stake in Aspen Pharmacare 3/13/2015
LMC Diabetes & Endocrinology And Manna Research Merge Research Programs 3/12/2015
Porton Fine Chemicals Pays $41.5 Million To Acquire Dongbang Pharma 3/12/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Tempted to Take Over $650 Million Galapagos (GLPG.BR) 3/11/2015
Baxter International (BAX) Snaps Up German Biopharma for $225 Million 3/5/2015
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO 3/5/2015
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged 3/4/2015
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business 3/3/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions 3/2/2015
JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate 2/26/2015
Phosphagenics Limited (POH.AX) Decides To Sell BioElixia Cosmetics Brand 2/25/2015
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/24/2015
Ipsen (IPN.PA) Enters Into Option Agreement To Acquire Canbex Therapeutics 2/24/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz 2/23/2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers 2/23/2015
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015
Management Buy Out Of Synexus Backed By LDC; The Deal Will Enable It To Further Expand Its Global Network 2/23/2015
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz 2/17/2015
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/16/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China 2/16/2015
Intrexon Corporation Snaps Up Belgium Startup ActoGeniX for $60 Million 2/13/2015
GlaxoSmithKline (GSK) Takes Full Control of GlycoVaxyn AG for $190 Million 2/11/2015
Cellular Biomedicine Group (CBMG) Acquires CAR-T Technology From China Hospital 2/9/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
AstraZeneca PLC (AZN) Slams Down $600 Million for Actavis (ACT) Lung Unit 2/5/2015
Hainan Shuangcheng Buys Hangzhou Ausia Biotech Stake For $154 Million 2/4/2015
Harbin Gloria Pharmaceuticals (002437.SZ) Acquires Shanxi Powerdone For $380 Million 2/4/2015
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/3/2015
Sanofi (SAN.PA)'s Increased Stake in Alnylam Pharmaceuticals (ALNY) Points Toward a Possible Acquisition 2/2/2015
ICON Snaps Up MediMedia Pharma Solutions for $120 MIllion Cash 2/2/2015
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Auxilium Pharmaceuticals (AUXL) 1/30/2015
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/29/2015
Pharma Giant Merck & Co. (MRK) Scoops Up UK Software Firm for Undisclosed Amount 1/29/2015
Actavis (ACT)' Buying Spree Continues With $460 Million Deal 1/27/2015
Biolin Scientific Acquires The Key Patent Protecting Multi-Hole, High-Throughput Ion Channel Screening 1/27/2015
genae Buys e-novex 1/27/2015
Novartis AG (NVS) CEO Taking a Hard Look at Swiss Costs, Possible Bolt-On Acquisitions 1/26/2015
AMATSIGROUP Acquires SEPS Pharma In Belgium, To Continue Its International Expansion And Strengthen Its Formulation Expertise 1/26/2015
3SBio Inc. (SSRX) Acquires Sirton Pharmaceuticals SpA 1/26/2015
Aspen Pharmacare Ltd. Grabs Rights to Novartis AG (NVS)'s Mono-Embolex for $142.3 Million 1/23/2015



//-->